Results 151 to 160 of about 81,803 (228)

Rare Atypical Ela3 BCR-ABL transcript in acute Lymphoblastic Leukemia: a case report. [PDF]

Afr Health Sci
Xu L, Han T, Wei S, Wang N.
europepmc   +1 more source

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension. [PDF]

J Pathol
Menegazzi G, Desideri D, Biagioni A, Rovida E, Dello Sbarba P, Peppicelli S.   +5 more
europepmc   +1 more source

BCR-ABL tyrosine kinase inhibitors associated acute kidney injury: a pharmacovigilance study based on the FAERS database with a case report. [PDF]

BMC Nephrol
Shi Y, Deng L, Zhu J, Huang Y, Zeng M, Mao H, Huang Z, Wu B.   +7 more
europepmc   +1 more source

Design, Docking Analysis, and Structure-Activity Relationship of Ferrocene-Modified Tyrosine Kinase Inhibitors: Insights into BCR-ABL Interactions. [PDF]

Molecules
Philipova I, Atanasova M, Mihaylova R, Dailova-Barzeva A, Ivanov SM, Simeonova RL, Stavrakov G.   +6 more
europepmc   +1 more source

Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms. [PDF]

Transl Oncol
Guo X, Jia W, Yang X, Jia H, Wu H, Wei Y, Can C, He N, Zhang H, Liu W, Yu S, Ma D.   +11 more
europepmc   +1 more source

BCR-ABL tyrosine kinase [PDF]

Science-Business eXchange, 2009
openaire   +3 more sources

GPX1 confers resistance to metabolic stress in BCR/ABL-T315I mutant chronic myeloid leukemia cells. [PDF]

Cell Death Discov
Wang JD, Wang JX, Lin ZL, Xu N, Zhang L, Liu JJ, Gao R, Long ZJ.   +7 more
europepmc   +1 more source

Correction to "Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML". [PDF]

J Phys Chem B
Carolina P Lima M, Hornsby BD, Lim CS, Cheatham TE.   +3 more
europepmc   +1 more source

Advances in Targeting BCR-ABL^T315I Mutation with Imatinib Derivatives and Hybrid Anti-Leukemic Molecules. [PDF]

Molecules
Tuzikiewicz A, Wawrzyniak W, Kutner A, Żołek T.   +3 more
europepmc   +1 more source

Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. [PDF]

J Pharmacol Exp Ther
Zhang Y, Yang CJ, Melrose AR, Pang J, Schofield K, Song SD, Parra-Izquierdo I, Zheng TJ, Lyssikatos JP, Gross SD, Shatzel JJ, McCarty OJT, Aslan JE.   +12 more
europepmc   +1 more source